Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Aetna acquires Humana for $35bn; blocked; later terminated

Executive Summary

Aetna Inc. acquired fellow publicly traded health care services company Humana Inc. for $35bn. For each Humana share, Aetna paid $125 in cash and 0.8375 Aetna shares (valued at $107), or a 21% premium. The combined entity will be owned 74% by Aetna and Humana the rest, and be led by Aetna's current chairman and CEO Mark Bertolini. The board will have reps from both Aetna (12) and Humana (four).
Deal Industry
  • Pharmaceuticals
  • Services
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register